Compounds > y 27632
Page last updated: 2024-09-03

y 27632 and Coronary Artery Disease

y 27632 has been researched along with Coronary Artery Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, T; Seto, M1
Shi, J; Surma, M; Wei, L1

Reviews

2 review(s) available for y 27632 and Coronary Artery Disease

ArticleYear
[Rho-kinase inhibitors].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2011, Volume: 138, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Clinical Trials as Topic; Coronary Artery Disease; Drug Design; Glaucoma; Humans; Hypertension, Pulmonary; Mice; Molecular Targeted Therapy; Pyridines; Rats; rho-Associated Kinases; Vasospasm, Intracranial

2011
Rho kinase as a therapeutic target in cardiovascular disease.
    Future cardiology, 2011, Volume: 7, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Apoptosis; Cardiovascular Diseases; Coronary Artery Disease; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Heart Failure; Humans; Male; Myocytes, Cardiac; Protein Isoforms; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Vasodilation

2011